GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (XSAT:EQL) » Definitions » 14-Day RSI
中文

EQL Pharma AB (XSAT:EQL) 14-Day RSI

: 62.54 (As of Today)
View and export this data going back to 2013. Start your Free Trial

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-04-24), EQL Pharma AB's 14-Day RSI is 62.54.

The industry rank for EQL Pharma AB's 14-Day RSI or its related term are showing as below:

XSAT:EQL's 14-Day RSI is ranked worse than
83.77% of 1140 companies
in the Drug Manufacturers industry
Industry Median: 45.21 vs XSAT:EQL: 62.54

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB 14-Day RSI Distribution

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's 14-Day RSI falls into.



EQL Pharma AB  (XSAT:EQL) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EQL Pharma AB  (XSAT:EQL) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


EQL Pharma AB 14-Day RSI Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


EQL Pharma AB (XSAT:EQL) Business Description

Traded in Other Exchanges
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (XSAT:EQL) Headlines

From GuruFocus